Showing results (821-830 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|June 26, 2013
Parthenolide enhances dacarbazine activity against melanoma cellsKamila Koprowska, Mariusz L Hartman, Malgorzata Sztiller-Sikorska, et al.
Anti-Cancer Drugs|June 26, 2013
Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1Marina Vettraino, Marcella Manerba, Marzia Govoni, et al.
Anti-Cancer Drugs|May 24, 2013
Bortezomid enhances the efficacy of lidamycin against human multiple myeloma cellsYong-Zhan Zhen, Ya-Jun Lin, Xiu-Jun Liu, et al.
Anti-Cancer Drugs|May 1, 2013
Ocimum sanctum Linn. (Tulsi): an ethnomedicinal plant for the prevention and treatment of cancerPiyali Bhattacharyya, Anupam Bishayee
Anti-Cancer Drugs|June 8, 2013
Inhibition of angiogenesis: a novel antitumor mechanism of the herbal compound arctigeninYuan Gu, Claudia Scheuer, Dilu Feng, et al.
Anti-Cancer Drugs|November 16, 2013
Jadomycins are cytotoxic to ABCB1-, ABCC1-, and ABCG2-overexpressing MCF7 breast cancer cellsMark E Issa, Steven R Hall, Stephanie N Dupuis, et al.
Anti-Cancer Drugs|November 13, 2013
Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxelOvidio Fernández, Javier Afonso, Sergio Vázquez, et al.
Anti-Cancer Drugs|August 22, 2013
Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases: a retrospective case seriesEmilie Le Rhun, Sophie Taillibert, Patrick Devos, et al.
Anti-Cancer Drugs|August 23, 2013
Vitexin 6, a novel lignan, induces autophagy and apoptosis by activating the Jun N-terminal kinase pathwayJun Zhou, Huiyong Hu, Jingpei Long, et al.
Anti-Cancer Drugs|October 9, 2013
Essential role of AKT in tumor cells addicted to FGFRYi Hu, Huiru Lu, Jinchao Zhang, et al.
Pageof 464